BKV insider files Form 144 to sell 10,000 common shares

Rhea-AI Filing Summary

BKV filed a Form 144 indicating a planned sale of 10,000 common shares, with an aggregate market value of $233,700. The approximate sale date is November 3, 2025, through Charles Schwab & Co., Inc. on the NYSE.

The shares were acquired as 5,111 founders shares on May 1, 2020 and 4,889 shares from a restricted stock lapse on January 1, 2025. Shares outstanding were 84,711,220 as of the filing’s reference line; this is a baseline figure, not the amount being sold.

In the past three months, the filer reported sales of 10,000 shares for $216,200 on August 12, 2025, 9,187 shares for $212,984 on September 2, 2025, and 15,000 shares for $347,816 on October 1, 2025.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Shares	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	10000	233700.00	84711220	11/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/01/2020	Founders Shares	BKV Corp			5111	05/01/2020	N/A
Common	01/01/2025	Restricted Stock Lapse	BKV Corp			4889	01/01/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	08/12/2025	10000	216200.00
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	09/02/2025	9187	212984.00
Lindsay B Larrick 1200 17TH ST., STE 2100 DENVER CO 80202	BKV Corp	10/01/2025	15000	347816.00

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did BKV (BKV) disclose in this Form 144?

A planned sale of 10,000 common shares with an aggregate market value of $233,700, expected around November 3, 2025.

Which broker and exchange are listed for the BKV Form 144 sale?

The sale is listed through Charles Schwab & Co., Inc. on the NYSE.

How were the BKV shares proposed for sale acquired?

The filing lists 5,111 founders shares acquired on May 1, 2020 and 4,889 shares from a restricted stock lapse on January 1, 2025.

How many BKV shares are outstanding for context?

Shares outstanding were reported as 84,711,220.

What recent BKV share sales by the filer were reported?

Reported sales include 10,000 shares for $216,200 on Aug 12, 2025, 9,187 for $212,984 on Sep 2, 2025, and 15,000 for $347,816 on Oct 1, 2025.

What class of securities is included in the BKV Form 144?

The filing covers common shares.